Koers Agentix Corp. Other OTC
Aandelen
AGTX
US00848A1034
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 3,91 mln. 3,63 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,79 mln. | Nettowinst (verlies) 2023 | -1 mln. -929K | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 145 134,64 | Nettoschuld 2023 | 37,63K 34,94K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-2,35
x | K/w-verhouding 2023 |
-2,86
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 76,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Salman Hoda
CHM | Chairman | 44 | 14-12-20 |
Martin Schroeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Fiene
AUD | Comptroller/Controller/Auditor | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rehan Huda
BRD | Director/Board Member | 54 | 02-07-20 |
Salman Hoda
CHM | Chairman | 44 | 14-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,61% | 89,08 mld. | |
+3,55% | 40,9 mld. | |
-14,40% | 32,25 mld. | |
+55,89% | 25,14 mld. | |
-15,96% | 15,39 mld. | |
-41,29% | 11,89 mld. | |
-15,50% | 11,91 mld. | |
-11,75% | 11,64 mld. | |
+7,87% | 9,03 mld. |